
Loading, please wait...

Loading, please wait...

Gleneagles Hospital has partnered with Medtronic India to launch a specialized Renal Denervation Therapy Centre at its Parel facility. This initiative specifically targets patients suffering from resistant hypertension. This condition occurs when blood pressure remains high despite the use of multiple medications. Consequently, the centre provides a structured approach to assessment and expert-led intervention. Doctors aim to reduce the risk of heart, brain, and kidney complications through this advanced technology. Therefore, the facility offers clinical evaluation, patient counseling, and medication optimization for eligible individuals.
The new centre will be led by a multidisciplinary team including Dr. Rahul Gupta and Dr. Bharat Shah. Renal Denervation Therapy serves as a minimally invasive procedure that targets overactive nerves in the renal arteries. By using radiofrequency energy, the therapy helps lower blood pressure levels significantly. Dr. Rahul Gupta noted that this therapy offers an additional option for carefully selected patients. Since resistant hypertension increases the risk of stroke and heart failure, early intervention remains crucial. Furthermore, the collaborative model ensures that cardiologists and nephrologists work together for personalized care pathways.
The facility focuses on more than just the surgical procedure. For instance, the team will emphasize lifestyle counseling and regular monitoring to ensure sustained control. Dr. Bharat Shah explained that uncontrolled hypertension can damage kidney function over time. Thus, the specialized centre helps identify high-risk patients early. Mandeep Singh Kumar of Medtronic India stated that the partnership aims to strengthen awareness and improve diagnosis. Moreover, the integration of clinical expertise with advanced technology supports better outcomes for complex cases. Patients will receive medication management support to achieve optimal health results.
Q1: What is resistant hypertension?
Resistant hypertension is a condition where a patient\'s blood pressure remains high even after they take three or more different types of antihypertensive medications.
Q2: How does renal denervation help patients?
The procedure uses radiofrequency energy to disrupt overactive nerves near the kidneys, which helps the body lower blood pressure more effectively.
Q3: Who is eligible for this therapy?
Eligible patients include those with uncontrolled blood pressure who have not responded to standard medical therapies and have been evaluated by a multidisciplinary medical team.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Gleneagles Hospital Mumbai and Medtronic India have launched a Renal Denervation Therapy Centre to treat patients with resistant hypertension....
7 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today